Volume | 1,347,717 |
|
|||||
News | - | ||||||
Day High | 5.228 | Low High |
|||||
Day Low | 5.065 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Caribou Biosciences Inc | CRBU | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.15 | 5.065 | 5.228 | 5.14 | 5.12 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
10,478 | 1,347,717 | $ 5.13 | $ 6,919,186 | - | 3.44 - 8.5899 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:32:53 | 2 | $ 5.13 | USD |
Caribou Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
463.31M | 90.31M | - | 13.85M | -99.42M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Caribou Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBU Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.58 | 5.77 | 5.05 | 5.21 | 1,401,668 | -0.45 | -8.06% |
1 Month | 8.12 | 8.22 | 4.99 | 5.84 | 1,824,506 | -2.99 | -36.82% |
3 Months | 5.24 | 8.33 | 4.69 | 6.08 | 1,619,242 | -0.11 | -2.10% |
6 Months | 4.69 | 8.33 | 3.44 | 5.50 | 1,598,098 | 0.44 | 9.38% |
1 Year | 4.67 | 8.5899 | 3.44 | 5.75 | 1,865,388 | 0.46 | 9.85% |
3 Years | 17.65 | 32.645 | 3.44 | 8.17 | 1,102,221 | -12.52 | -70.93% |
5 Years | 17.65 | 32.645 | 3.44 | 8.17 | 1,102,221 | -12.52 | -70.93% |
Caribou Biosciences Description
Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. |